FBXW7 in breast cancer: mechanism of action and therapeutic potential

Abstract Breast cancer is one of the frequent tumors that seriously endanger the physical and mental well-being in women. F-box and WD repeat domain-containing 7 (FBXW7) is a neoplastic repressor. Serving as a substrate recognition element for ubiquitin ligase, FBXW7 participates in the ubiquitin–pr...

Full description

Bibliographic Details
Main Authors: Siyu Chen, Ping Leng, Jinlin Guo, Hao Zhou
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-023-02767-1
_version_ 1827632699367489536
author Siyu Chen
Ping Leng
Jinlin Guo
Hao Zhou
author_facet Siyu Chen
Ping Leng
Jinlin Guo
Hao Zhou
author_sort Siyu Chen
collection DOAJ
description Abstract Breast cancer is one of the frequent tumors that seriously endanger the physical and mental well-being in women. F-box and WD repeat domain-containing 7 (FBXW7) is a neoplastic repressor. Serving as a substrate recognition element for ubiquitin ligase, FBXW7 participates in the ubiquitin–proteasome system and is typically in charge of the ubiquitination and destruction of crucial oncogenic proteins, further performing a paramount role in cell differentiation, apoptosis and metabolic processes. Low levels of FBXW7 cause abnormal stability of pertinent substrates, mutations and/or deletions in the FBXW7 gene have been reported to correlate with breast cancer malignant progression and chemoresistance. Given the lack of an effective solution to breast cancer's clinical drug resistance dilemma, elucidating FBXW7's mechanism of action could provide a theoretical basis for targeted drug exploration. Therefore, in this review, we focused on FBXW7's role in a range of breast cancer malignant behaviors and summarized the pertinent cellular targets, signaling pathways, as well as the mechanisms regulating FBXW7 expression. We also proposed novel perspectives for the exploitation of alternative therapies and specific tumor markers for breast cancer by therapeutic strategies aiming at FBXW7.
first_indexed 2024-03-09T14:49:14Z
format Article
id doaj.art-50d4e153c4e342b5b0c774dd4a9e9f1d
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-03-09T14:49:14Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-50d4e153c4e342b5b0c774dd4a9e9f1d2023-11-26T14:34:49ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662023-09-0142111810.1186/s13046-023-02767-1FBXW7 in breast cancer: mechanism of action and therapeutic potentialSiyu Chen0Ping Leng1Jinlin Guo2Hao Zhou3Chongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosisand, Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology , Chengdu University of Traditional Chinese MedicineChongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosisand, Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology , Chengdu University of Traditional Chinese MedicineChongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosisand, Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology , Chengdu University of Traditional Chinese MedicineChongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosisand, Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology , Chengdu University of Traditional Chinese MedicineAbstract Breast cancer is one of the frequent tumors that seriously endanger the physical and mental well-being in women. F-box and WD repeat domain-containing 7 (FBXW7) is a neoplastic repressor. Serving as a substrate recognition element for ubiquitin ligase, FBXW7 participates in the ubiquitin–proteasome system and is typically in charge of the ubiquitination and destruction of crucial oncogenic proteins, further performing a paramount role in cell differentiation, apoptosis and metabolic processes. Low levels of FBXW7 cause abnormal stability of pertinent substrates, mutations and/or deletions in the FBXW7 gene have been reported to correlate with breast cancer malignant progression and chemoresistance. Given the lack of an effective solution to breast cancer's clinical drug resistance dilemma, elucidating FBXW7's mechanism of action could provide a theoretical basis for targeted drug exploration. Therefore, in this review, we focused on FBXW7's role in a range of breast cancer malignant behaviors and summarized the pertinent cellular targets, signaling pathways, as well as the mechanisms regulating FBXW7 expression. We also proposed novel perspectives for the exploitation of alternative therapies and specific tumor markers for breast cancer by therapeutic strategies aiming at FBXW7.https://doi.org/10.1186/s13046-023-02767-1FBXW7Breast cancerncRNAs regulationAngiogenesisImmune escapeDrug resistance
spellingShingle Siyu Chen
Ping Leng
Jinlin Guo
Hao Zhou
FBXW7 in breast cancer: mechanism of action and therapeutic potential
Journal of Experimental & Clinical Cancer Research
FBXW7
Breast cancer
ncRNAs regulation
Angiogenesis
Immune escape
Drug resistance
title FBXW7 in breast cancer: mechanism of action and therapeutic potential
title_full FBXW7 in breast cancer: mechanism of action and therapeutic potential
title_fullStr FBXW7 in breast cancer: mechanism of action and therapeutic potential
title_full_unstemmed FBXW7 in breast cancer: mechanism of action and therapeutic potential
title_short FBXW7 in breast cancer: mechanism of action and therapeutic potential
title_sort fbxw7 in breast cancer mechanism of action and therapeutic potential
topic FBXW7
Breast cancer
ncRNAs regulation
Angiogenesis
Immune escape
Drug resistance
url https://doi.org/10.1186/s13046-023-02767-1
work_keys_str_mv AT siyuchen fbxw7inbreastcancermechanismofactionandtherapeuticpotential
AT pingleng fbxw7inbreastcancermechanismofactionandtherapeuticpotential
AT jinlinguo fbxw7inbreastcancermechanismofactionandtherapeuticpotential
AT haozhou fbxw7inbreastcancermechanismofactionandtherapeuticpotential